Gov. Hochul signs legislation to cap out-of-pocket costs for EpiPen devices
The cost of epinephrine auto-injector devices, commonly known as "EpiPen" devices, is slated to become a little more affordable for families due to legislation recently signed into law in
Governor
"For people with severe allergies, immediate access to an EpiPen device can mean the difference between life and death,"
"When every second counts, the last thing New Yorkers should have to worry about is whether they can afford the medication they need to survive an anaphylactic reaction. By signing this bill, we are putting people over profit and giving New Yorkers peace of mind by ensuring equitable access to this lifesaving emergency treatment."
Epi-Pens have a relatively short shelf-life, expiring after 12 months on average, requiring those in need to purchase the medication repeatedly. Adding to their expense, users of Epi-Pens are also advised to carry two devices at all times, as a single dose of epinephrine may not be enough to treat a serious allergic reaction. Acquiring the devices requires a prescription from a healthcare provider. Due to the rising costs, many who are prescribed the auto-injectors, try to stretch out their supply by going beyond expiration dates or delaying picking up their prescriptions.
The potentially life saving devices rose sharply in cost over the last decade, due in large part to
From 2007 to 2016 the average cost of the devices rose from
Shkreli, who was the CEO of
For his role in a large scale Ponzi scheme Shkreli was charged and convicted of two counts of securities fraud and Conspiracy to commit securities fraud. He was sentenced to seven years in prison and was paroled after six years and five months.
He was also ordered to pay
State officials say the legislation is in line with the "consistent efforts" of Hochul to "make health and human services more affordable in
"


If CT health system doesn't reach contract agreement with insurer, what it could mean for patients
Insurance is what makes US health-care prices so high
Advisor News
- Wealth planning vs. estate planning: Honoring your client’s wishes
- What to discuss during the first retirement planning meeting
- Inflation, competing priorities and uncertainty erode retirement security
- As health premiums rise, 1 in 8 workers cut retirement savings
- CT governor’s candidates claims: What’s true, and what’s misleading
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- How the law protecting Americans from surprise medical bills is driving up healthcare costs
- Medicare Plus supplement vs. Medicare Advantage (Maybe) 2026– Healthful Hints
- ‘Medically frail’ Medicaid enrollees won’t have to prove their inability to work to keep coverage
- IMPLEMENTATION OF IMMIGRANT ELIGIBILITY RESTRICTIONS FOR ACA MARKETPLACE SUBSIDIES UNDER THE 2025 RECONCILIATION LAW: ISSUES TO CONSIDER
- ACA HEALTH INSURANCE RATES RELEASED FOR 2027 OPEN ENROLLMENT
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Insignia Life S.A. de C.V.
- FINANCIAL FRAUD
- Security Benefit Announces Planned Dividend Rate Reset for Series B Preferred Stock
- Palmetto Heritage and Atlantic Coast Life Announce Discussions Regarding Potential Acquisition
- Jury finds insurance company acted in bad faith, awards Nebraska woman $11.3M
More Life Insurance News